UNC Has Key Role in COVID-19 Drug Nearly Ready for Human Trials

Posted Apr 8, 2020
Scientists in Ralph Baric’s lab at UNC are playing a key role in the development and testing of a new drug, called EIDD-2801, that could change the way doctors treat COVID-19. The drug shows promise in reducing lung damage, has finished testing in mice and will soon move to human clinical trials. Baric is UNC’s Kenan Distinguished Professor of epidemiology. (Carolina Alumni Review)

Related: Campus Connections

Suki Lin: UNC’s hidden gem
UNC is filled with notable figures but there is one bright star on UNC’s YikYak: the corgi, Suki Lin. Suki first became known to the...
Sun May 4, 2025

Jim Lampley wasn't supposed to fall in love with boxing. Instead, he became its voice
Jim Lampley has been the voice of boxing for a generation, which is remarkable because the assignment was only supposed to last one fight. In...
Fri May 2, 2025

Meet the Carolina Class of 2025
More than 6,800 Tar Heels, including undergrad, graduate and professional students, will have their Carolina degrees conferred at Spring Commencement on May 10. More than...
Thu May 1, 2025

Carolina biologist wins Wolf Prize in Agriculture
Jeffery L. Dangl, a biologist at UNC-Chapel Hill, was part of an award-winning trio of researchers who received the 2025 Wolf Prize in Agriculture “for...
Tue Apr 29, 2025